| ²é¿´: 2382 | »Ø¸´: 8 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
[½»Á÷]
¹ØÓÚBiomaterialsͶ¸å
|
||||
|
µÚÒ»´ÎͶBiomaterials£¬ÓкöàÎÊÌâ²»ÊÇÌ«¶®£¬ËͶ¹ý¸øÐ©½¨Òé¡£ 1.ʵÑéÊý¾ÝÊDz»ÊÇ·ÅÔÚÎÄÕµÄ×îºóÃæ 2.A template for the covering letter is found on the Biomaterials website.ÎÒûÕÒµ½£¬ÏëÎÊÒ»ÏÂÄãÃÇÔÚÄÄÕÒµ½µÄ |
» ²ÂÄãϲ»¶
ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË
ÒѾÓÐ10È˻ظ´
ÈËÆø²»ÐÐÁË
ÒѾÓÐ11È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ22È˻ظ´
µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡
ÒѾÓÐ3È˻ظ´
2026ÄêµÄ¹ú¼ÒÉç¿Æ»ù½ðÏîĿͨѶÆÀÉóµÄйæÔòÓëж¯Ïò¡¢ÐÂÌôÕ½
ÒѾÓÐ7È˻ظ´
½ñÌì»ù½ð»á³ö½á¹ûÂð£¿20260819
ÒѾÓÐ18È˻ظ´
ÎÒÃæÉÏÍêµ°ÁË
ÒѾÓÐ14È˻ظ´
·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë
ÒѾÓÐ8È˻ظ´
Ö»ÓÐÿÄêÕâÖÖʱºòÀ´¹ä¹äСľ³æ
ÒѾÓÐ27È˻ظ´
Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿
ÒѾÓÐ5È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
¹ØÓÚһƪÎÄÏ×µÄÌâÄ¿
ÒѾÓÐ5È˻ظ´
2012 SCI impact factor ÉúÎï²ÄÁÏÀà ÆÀµã
ÒѾÓÐ9È˻ظ´
ÂÛÎÄͶ¸å¿¯ÎïÑ¡Ôñ
ÒѾÓÐ1È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¸æ±ðÁ÷Ë®ÏßˬÎÄ£¡108Íò×ÖÍê½áÏÉÏÀ¡¶Å®æ´Ê¯Ö®ÁéÊ¯ÆæÔµ£¨ÏÉ½çÆª£©¡·ÖµµÃϸƷ
+1/5026
Сľ³æÈÏʶµÄÀϹ«ÔÚÒ»Æð11Ä꣬ȥÊÀ¿ì100ÌìÁË¡£
+2/360
Õæ³ÏÕ÷ÓÑ
+1/182
»ù½ðÆí¸£
+1/154
É¢½ð±Ò
+1/121
ÉϺ£½»Í¨´óѧÕź½¿ÎÌâ×éÕÐÆ¸²©Ê¿ºó£¨µç»¯Ñ§ÄÜÁ¿´æ´¢Óëת»»£©
+1/98
»ªÖпƼ¼´óѧÂÞ־ǿ½ÌÊÚ¿ÎÌâ×éÕÐÊÕ2027ÄêÇï¼¾Èëѧ²©Ê¿Ñо¿Éú
+2/70
Î人£¬³ÏÕ÷ÄÐÓÑ£¬²»ÒìµØ£¬ÄêÁä´óÁË
+1/37
2027Ä격ʿÉêÇë
+1/6
ÄϾ©´óѧ ÖÇÄÜÇý¶¯Óë¸ÐÖª²ÄÁÏʵÑéÊÒ ³ÏÕÐÉêÇ뿼ºË²©Ê¿Éú/¿ÆÑÐÖúÀí/²©Ê¿ºó
+1/4
ÖпÆÔº´óÁ¬»¯Ñ§ÎïÀíÑо¿Ëù ÕÐÆ¸ ´ß»¯¼ÁÑз¢·½Ïò ¿ÆÑÐÖúÀí 2Ãû
+1/4
¶àÒò×Óµ°°×¼ì²âÔÚϵͳÐÔºì°ßÀÇ´¯£¨SLE£©Ñо¿ÖеÄÓ¦ÓÃ
+1/4
Æíµ»ÀϹ«Öйú»ù
+1/3
Ïôó»¯Ôºº£ÓÅÍŶÓÕÐÊÕ2027¼¶¡¾²©Ê¿¡¿ºÍ¡¾ÍÆÃâ˶ʿ¡¿Ñо¿Éú¸÷2Ãû
+1/2
³öȫвÌ˾ Plan?APOCHROMAT 20¡Á/0.8 ƽ³¡¸´ÏûÉ«²îÎï¾µ
+1/2
ÐÂÉó²éÖ¸ÄÏÊ©ÐаëÄ꣬AI·½ÏòµÄרÀûÉêÇëÊDz»ÊǸü¿´"¼¼Êõζ"ÁË£¿
+1/2
ÄÏ·½Ò½¿Æ´óѧÉîÛÚÒ½Ôº³ÂìÇ/ÓàÌνÌÊÚ¿ÎÌâ×éÁªºÏÅàÑø²©Ê¿ºóÕÐÆ¸
+1/2
µ¥Ï¸°û²âÐòÑù±¾ÖƱ¸ÓëÖÊ¿ØÔËÊäÈ«Á÷³ÌÖ¸ÄÏ
+1/1
¡¾¿ÆÑÐÏîÄ¿Õ÷¼¯¡¿Ò»Ïî¿ÉÔÚ 4¡ª8 ÖÜÍê³ÉµÄСÈÎÎñ£¬Ò²ÖµµÃ±»ÈÏÕæ¶Ô´ý
+1/1
¡¾½»²æ¿ÆÑкÏ×÷¡¿³ÏÑû¶àѧ¿Æ½ÌÊÚ¡¢²©Ê¿¹²½¨Ñ§Éúʵ¼ù¿ÎÌâ¿â
+1/1
|
ÿ¸öÊý¾ÝÊǵ¥¶ÀµÄÒ»¸öword, author declarationҪǩÉÏËùÓÐ×÷ÕßµÄÓ¢ÎÄÃû×Ö²»ÊÇcover letter |
7Â¥2013-04-23 08:50:25
nono2009
³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)
-

ר¼Ò¾Ñé: +21105 - SEPI: 10
- Ó¦Öú: 28684 (Ժʿ)
- ¹ó±ö: 513.911
- ½ð±Ò: 2555230
- Ìû×Ó: 1602255
- ÔÚÏß: 65200.9Сʱ
- ³æºÅ: 827383
¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
shmily1972: ½ð±Ò+1 2012-11-18 09:04:24
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
shmily1972: ½ð±Ò+1 2012-11-18 09:04:24
|
Â¥Ö÷ÊÇ¿´µÄÕâÀïÂð£ºhttp://www.elsevier.com/journals ... 2/guide-for-authors ÕâôûÓв鵽Äã˵µÄA template for the covering letter is found on the Biomaterials website |
2Â¥2012-11-17 19:30:02
3Â¥2012-11-17 22:01:53
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
shmily1972: ½ð±Ò+5 2012-11-18 09:19:43
esub: »ØÌûÖö¥ 2013-04-24 17:07:15
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
shmily1972: ½ð±Ò+5 2012-11-18 09:19:43
esub: »ØÌûÖö¥ 2013-04-24 17:07:15
|
Ç×£¬Äã¿ÉÒÔÔÚEESµÄÖ÷Ò³ÉϵÄÓÒ±ßÀ¸ÉϵãAuthor declaration£¬È»ºó¾Í»áÖ±½ÓÏÂÔØÒ»¸öword°æ±¾µÄauthor declaration£¬¶ø A template for the covering letter will be found at the end of this document£ºË³±ã¸øÄã¸´ÖÆÁËÒ»¸ö£¬ÒòΪºÃ»¹²»»áÓø½¼þ°¡ We the undersigned declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere. We would like to draw the attention of the Editor to the following publications of one or more of us that refer to aspects of the manuscript presently being submitted. Where relevant copies of such publications are attached. [CAN BE DELETED IF NOT RELEVANT] We wish to draw the attention of the Editor to the following facts which may be considered as potential conflicts of interest and to significant financial contributions to this work. [OR] We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property. We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. [CAN BE DELETED IF NOT RELEVANT] We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from biomaterials@online.be. Signed by all authors as follows: [LIST AUTHORS AND DATED SIGNATURES ALONGSIDE] |
4Â¥2012-11-17 22:38:10









»Ø¸´´ËÂ¥